20/20 Biolabs, Inc. - AIDX
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cresset Asset Management, LLC | History | New | 264,368 | 497 | 0.0% | — | 1 | +264,368 | New | Q1 2026 | May 15, 2026 |
| CITADEL ADVISORS LLC | History | New | 16,227 | 30 | 0.0% | — | 2 | +16,227 | New | Q1 2026 | May 15, 2026 |
| XTX Topco Ltd | History | New | 10,329 | 19 | 0.0% | — | 3 | +10,329 | New | Q1 2026 | May 15, 2026 |
| UBS Group AG | History | New | 8,314 | 15 | 0.0% | — | 4 | +8,314 | New | Q1 2026 | May 05, 2026 |
| MAI Capital Management | History | New | 1,000 | 1 | 0.0% | — | 5 | +1,000 | New | Q1 2026 | May 15, 2026 |
| TOTH FINANCIAL ADVISORY CORP | History | New | 157 | 0 | — | — | — | +157 | New | Q1 2026 | Apr 16, 2026 |
| Allworth Financial LP | History | New | 30 | 0 | — | — | — | +30 | New | Q1 2026 | May 14, 2026 |